Home Daily Digests Tech Skeptics, Anti-Semitism, Pain Profiteering, and Pharma Triumphs

Tech Skeptics, Anti-Semitism, Pain Profiteering, and Pharma Triumphs

From tech skepticism to pharma triumphs, we’re diving into the deep end of the news pool. Buckle up for a journey through Elon Musk’s critics, alleged anti-Semitism, pain profiteering, and AstraZeneca’s surprising success story.

user profile picture Ivor Nov 10, 2023
placeholder image

DISCLAIMER: The following content does not reflect the opinions of Peak Prosperity, but is rather a summarization of content that has caught the interest of members of the community.

Discussion is welcome in the comments section!

In the realm of technology, a recent podcast hosted by Derrick Broze of The Conscious Resistance brought together journalists and researchers to discuss public skepticism towards Elon Musk. The conversation, featuring Whitney Webb, James Corbett, Jason Bermas, and Ryan Cristián, revolved around the themes of technocracy and transhumanism.

In international news, several prominent news outlets, including The New York Times and The Financial Times, have published articles portraying Russia and China as anti-Semitic and anti-Israel. This portrayal comes amidst the US’s attempts to undermine Moscow and Beijing’s efforts to play a larger role in the Palestine-Israel peace process. The US’s strategy appears to be to maintain its monopoly over the peace process by discrediting Russia and China’s involvement through accusations of anti-Semitism and anti-Israel sentiment. However, the global majority seems ready for a more balanced approach, as indicated by increasingly lopsided UN votes that isolate the US.

Turning to the medical industry, a recent text highlighted the prioritization of financial gain in the pain industry and the issue of profiteering during the COVID-19 pandemic. The text discussed the risks and limitations associated with NSAIDs and opioids, the suppression of potential cures that could threaten profitable markets, and instances of corruption within the medical industry. The text also emphasized the drawbacks of relying solely on MRI findings for assessing back pain and introduced alternative treatments.

In pharmaceutical news, AstraZeneca has increased its earnings forecasts for the year, with surging sales of cancer medicines offsetting plummeting sales of COVID vaccines. The company’s revenues were largely driven by a 17% increase in sales of cancer drugs, particularly its cancer immunotherapy drug Imfinzi. Despite a 65% drop in sales from the firm’s vaccine & immune therapies division, AstraZeneca’s sales increased in all regions worldwide, apart from China. The company attributed the drop in sales from China to a reduction in promotional activities due to an anti-corruption campaign led by Chinese health authorities. AstraZeneca also announced an exclusive licensing agreement with Shanghai company Eccogene to develop and sell its experimental ECC5004 drug as a treatment for obesity.


AstraZeneca Raises Earnings Forecasts as Cancer Drug Sales Offset Decline in COVID Vaccine Sales

The uptick in AstraZeneca’s revenues was largely driven by a 17% increase in sales of cancer drugs at constant exchange rates, to $4.66 billion, on the back of 53% higher sales of its cancer immunotherapy drug Imfinzi.

Source | Submitted by thebiotechnologist

Profit-Driven Medical Industry: Dangerous Therapies, Fraudulent Practices, and the Neglected Spine

Source | Submitted by nils-grimley

Western Media Attempts to Paint Russia and China as Anti-Semitic and Anti-Israel in Propaganda Effort

The New York Times, Financial Times, Wall Street Journal, and The Telegraph have all recently run pieces attempting to paint Russia and China as anti-Semitic and/or anti-Israel.

Source | Submitted by nils-grimley

Experts Warn Public to Be Skeptical of Elon Musk, Cite Concerns over Technocracy and Transhumanism

the public should be extremely skeptical of Elon Musk.

Source | Submitted by nils-grimley

Submit News to the Daily Digest

Do you have news you think the community will find interesting? Submit it here!

Please login to submit a story to the Daily Digest.